The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis

被引：1
|
作者：
van de Kerkhof, P. C. M. [1 ]
机构：
[1] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, Nijmegen, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 05期
关键词：
D O I：
10.1111/bjd.20624
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：879 / 879
页数：1
相关论文
共 50 条
  • [41] Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 562 - 564
  • [42] BUDGET IMPACT MODEL OF SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS (AS) AND WITH PSORIATIC ARTHRITIS (PSA) IN ITALY
    Colombo, G. L.
    Di Matteo, S.
    Bruno, G. M.
    Valentino, M. C.
    Oselin, M.
    Roccia, A.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
  • [43] INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS TREATED WITH SECUKINUMAB: POOLED ANALYSIS OF 21 RANDOMISED CONTROLLED PHASE 3/ 4 CLINICAL TRIALS OF PSORIASIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Schreiber, Stefan
    Colombel, Jean-Frederic
    Feagan, Brian G.
    Reich, Kristian
    Deodhar, Atul
    McInnes, Iain B.
    Porter, Brian
    Das Gupta, Ayan
    Pricop, Luminita
    Fox, Todd
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 18 - 18
  • [44] SACROILIITIS IN PATIENTS WITH PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS ARE THERE DIFFERENCES?
    Luppino-Assad, R.
    Dalto, V.
    Oliveira, R.
    Nogueira-Barbosa, M.
    Louzada-Junior, P.
    Sampaio-Barros, P. D.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S142 - S142
  • [45] SACROILIITIS IN PATIENTS WITH PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS - ARE THERE DIFFERENCES?
    Luppino-Assad, R.
    de Oliveira, R.
    Nogueira-Barbosa, M. H.
    Louzada-Junior, P.
    Dalto, V. F.
    Sampaio-Barros, P. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 711 - 712
  • [46] Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?
    Chandran, Vinod
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (04) : 329 - 334
  • [47] COST PER TREATED PATIENT FOR BIOLOGICS IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, PSORIASIS AND ANKYLOSING SPONDYLITIS USING CLAIMS DATA
    Bonafede, M. M.
    Joseph, G.
    Princic, N.
    Harrison, D. J.
    VALUE IN HEALTH, 2013, 16 (03) : A220 - A220
  • [48] Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis
    Peters, MJ
    van der Horst-Bruinsma, IE
    Dijkmans, BA
    Nurmohamed, MT
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 34 (03) : 585 - 592
  • [49] Risk: Benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis
    Fleischmann, Roy
    Iqbal, Imran
    DRUGS & AGING, 2007, 24 (03) : 239 - 254
  • [50] MALIGNANCY RISK IN MALE PATIENTS WITH ANKYLOSING SPONDYLITIS
    Nam, Bora
    Kim, Hyoungyoung
    Jang, Eun Jin
    Cho, Soo-Kyung
    Sung, Yoon-Kyoung
    Kim, Tae-Hwan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 635 - 635
12345